Viewing Study NCT02037256


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-03-05 @ 12:30 AM
Study NCT ID: NCT02037256
Status: COMPLETED
Last Update Posted: 2021-05-10
First Post: 2014-01-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2008-134
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View